add site
services
publishers
database
health videos
toolbar
stats
live show
health store
more stuff
JOIN/LOGIN
| advertise add site services publishers database health videos
| | about toolbar stats live show health store more stuff JOIN/LOGIN |
| Health World US Business Political Technology Entertainment Sports Popular |
Video: Boston Scientific Announces European Approval and Launch of Platinum ...Reuters - Nov 2, 2009 "The platinum chromium alloy and new stent design used in the PROMUS Element stent represent significant innovations in drug-eluting stent technology," said ... Boston Scientific's Promus Element stent wins CE Mark Mass Device blogs (blog) Boston Sci's Promus Element Stents Approved In Europe Wall Street Journal SurModics, Inc.Q4 2009 Earnings Call TranscriptSeeking Alpha (blog) - Nov 4, 2009 However, drug eluting stent penetration rates increased to an estimated 75% in the United States, up from 715 in the year earlier period. ... Edge dissection assessed in patients with drug-eluting stentsCardiology Today - Nov 2, 2009 Researchers have determined the incidence of and predictive factors for edge dissections in patients who received drug-eluting stents from 2004 to 2006. ... VELETI in print: Plaque sealing of SVGs a strategy "ahead of its time"?TheHeart.Org - - Nov 4, 2009 Specifically, PCI with drug-eluting stents (DES) has been associated with low rates of major adverse cardiovascular events (MACE) and restenosis, ... Boston Scientific shares slump on dim outlookThe Associated Press - Oct 20, 2009 "The growth rates in Boston Scientific's key end markets, drug-eluting stents and cardiac rhythm management, are decelerating and we expect Boston ... Boston Scientific Faces Pricing Pressure Morningstar.ca Boston Scientific Company Q3 2009 Earnings Call Transcript Seeking Alpha (blog) Highlights From BSX's Q3 Conference Call: Climate Still Remains Challenging ... StreetInsider.com (subscription) By: Zacks Equity ResearchZacks.com - Nov 5, 2009 REG-Biocompatibles Intl.: Interim Management StatementReuters - Nov 3, 2009 We also have a PC Licensing agreement with Medtronic Inc. in the field of Drug-Eluting Stents. This news release contains forward-looking statements that ... REG-Biocompatibles Intl.: Statement re Positive Data in Combination Therapy TrialReuters - Nov 3, 2009 HHS subpoenas Boston Scientific's CRM divisionMass Device - 21 hours ago Taxus sales have declined significantly over the past two years as competition has stiffened from other drug-eluting stent makers like Medtronic or Johnson ... Higher carotid arterial stenting rates associated with poorer clinical outcomesEurekAlert (press release) - 20 hours ago ... has researched the impact of cardiac devices, including drug-eluting stents and implantable cardioverter-defibrillators, for more than 15 years, ... | How to call the show... 1) Make sure the show is live (see graphic above). 2) Dial 724-444-7444. 3) Enter Call ID# 27566 when prompted. 4) Follow the phone prompts to join the call. Would you like to be a special guest on the show? Send us an email which includes your contact information and the topic(s) that you would like to discuss. Listen to past shows featuring special guests...  Bernard von NotHaus (Liberty Dollar)Aubrey de Grey, PhDDr. Amanuel Sima, MDDr. Bard Levey, DDSNeal AdamsRobin Scovill (director)Richard Diaz (author)Dr. Kaayla T. Daniel, CCNChana de Wolf, (cryonics researcher)Dr. Mary Ruwart (author & scientist)Richard Diaz (author)Dr. Jason Helliwell, OB/GYN |
| ↑ top of page ↑ | about thumbshots |
